Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas
Status:
Completed
Trial end date:
2019-12-10
Target enrollment:
Participant gender:
Summary
This study is an extension to re-treat partial and non-responders from the previously
approved Phase 1 MCS-AFP protocols IRB #12-009716 (Crohn's Disease perianal fistulas) and
15-003200 (cryptoglandular perianal fistulas).